Nosocomial transmission of Serratia marcescens in a veterinary hospital due to contamination by benzalkonium chloride.
During a 1-year period, Serratia marcescens was isolated from 50% of all contaminate intravenous catheters from dogs and cats in a large veterinary hospital. S. marcescens was also isolated from respiratory tracts, genitourinary tracts, skin, and other sites in hospitalized animals. A total of 55% of the clinical isolates and 66% of the intravenous catheter isolates had the same API biochemical profile. The source of the S. marcescens was determined to be aqueous benzalkonium chloride (0.025%) sponge pots located in the intensive care unit, surgery rooms, and outpatient clinic areas of the hospital. Of the 11 S. marcescens isolates submitted to the Centers for Disease Control for serotyping (6 from aqueous benzalkonium chloride sponge pots, 5 from intravenous catheters), 8 were identified as serotype O10:H11. All S. marcescens isolates tested for antibiotic susceptibilities were multiply resistant; isolates were most frequently resistant to streptomycin, cephalothin, and ampicillin. This study demonstrates that improper use of disinfectants plays an important role in the nosocomial transmission of S. marcescens.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001424:Bacterial Infections / Q000635:transmission / Q000662:veterinary*; D001548:Benzalkonium Compounds; D002371:Cat Diseases / Q000635:transmission; D002404:Catheterization / Q000295:instrumentation; D002415:Cats; D003428:Cross Infection / Q000662:veterinary*; D004283:Dog Diseases / Q000635:transmission; D004285:Dogs; D007263:Infusions, Parenteral / Q000295:instrumentation; D012703:Serotyping; D012706:Serratia marcescens / Q000145:classification / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents; D001548:Benzalkonium Compounds